Andrew C. W. Zannettino
Andrew C. W. Zannettino
Verified email at - Homepage
Cited by
Cited by
Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow
S Gronthos, ACW Zannettino, SJ Hay, S Shi, SE Graves, A Kortesidis, ...
Journal of cell science 116 (9), 1827-1835, 2003
Mechanisms of magnesium‐stimulated adhesion of osteoblastic cells to commonly used orthopaedic implants
H Zreiqat, CR Howlett, A Zannettino, P Evans, G Schulze‐Tanzil, C Knabe, ...
Journal of Biomedical Materials Research: An Official Journal of The Society …, 2002
Multipotential human adipose‐derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo
ACW Zannettino, S Paton, A Arthur, F Khor, S Itescu, JM Gimble, ...
Journal of cellular physiology 214 (2), 413-421, 2008
OCT-1–mediated influx is a key determinant of the intracellular uptake of imatinib but not nilotinib (AMN107): reduced OCT-1 activity is the cause of low in vitro sensitivity …
DL White, VA Saunders, P Dang, J Engler, ACW Zannettino, ...
Blood 108 (2), 697-704, 2006
Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells
A Kortesidis, A Zannettino, S Isenmann, S Shi, T Lapidot, S Gronthos
Blood 105 (10), 3793-3801, 2005
The therapeutic applications of multipotential mesenchymal/stromal stem cells in skeletal tissue repair
A Arthur, A Zannettino, S Gronthos
Journal of cellular physiology 218 (2), 237-245, 2009
Concise review: mesenchymal stromal cells: potential for cardiovascular repair
PJ Psaltis, ACW Zannettino, SG Worthley, S Gronthos
Stem cells 26 (9), 2201-2210, 2008
Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity
DL White, VA Saunders, P Dang, J Engler, A Venables, S Zrim, ...
Blood, The Journal of the American Society of Hematology 110 (12), 4064-4072, 2007
Differential cell surface expression of the STRO‐1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells
S Gronthos, ACW Zannettino, SE Graves, S Ohta, SJ Hay, PJ Simmons
Journal of Bone and Mineral Research 14 (1), 47-56, 1999
Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib
AL Dewar, AC Cambareri, ACW Zannettino, BL Miller, KV Doherty, ...
Blood 105 (8), 3127-3132, 2005
Osteoclasts control reactivation of dormant myeloma cells by remodelling the endosteal niche
MA Lawson, MM McDonald, N Kovacic, W Hua Khoo, RL Terry, J Down, ...
Nature communications 6 (1), 8983, 2015
Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1α, 25-dihydroxyvitamin D3
GJ Atkins, PH Anderson, DM Findlay, KJ Welldon, C Vincent, ...
Bone 40 (6), 1517-1528, 2007
N-cadherin in cancer metastasis, its emerging role in haematological malignancies and potential as a therapeutic target in cancer
KM Mrozik, OW Blaschuk, CM Cheong, ACW Zannettino, K Vandyke
BMC cancer 18 (1), 939, 2018
RANKL expression is related to the differentiation state of human osteoblasts
GJ Atkins, P Kostakis, B Pan, A Farrugia, S Gronthos, A Evdokiou, ...
Journal of Bone and Mineral Research 18 (6), 1088-1098, 2003
EZH2 and KDM6A Act as an Epigenetic Switch to Regulate Mesenchymal Stem Cell Lineage Specification
S Hemming, D Cakouros, S Isenmann, L Cooper, D Menicanin, ...
Stem cells 32 (3), 802-815, 2014
Positioning of bone marrow hematopoietic and stromal cells relative to blood flow in vivo: serially reconstituting hematopoietic stem cells reside in distinct nonperfused niches
IG Winkler, V Barbier, R Wadley, ACW Zannettino, S Williams, ...
Blood, The Journal of the American Society of Hematology 116 (3), 375-385, 2010
Receptor activator of nuclear factor-κB ligand expression by human myeloma cells mediates osteoclast formation in vitro and correlates with bone destruction in vivo
AN Farrugia, GJ Atkins, LB To, B Pan, N Horvath, P Kostakis, DM Findlay, ...
Cancer research 63 (17), 5438-5445, 2003
The proliferation and phenotypic expression of human osteoblasts on tantalum metal
DM Findlay, K Welldon, GJ Atkins, DW Howie, ACW Zannettino, D Bobyn
Biomaterials 25 (12), 2215-2227, 2004
Elevated serum levels of stromal-derived factor-1α are associated with increased osteoclast activity and osteolytic bone disease in multiple myeloma patients
ACW Zannettino, AN Farrugia, A Kortesidis, J Manavis, LB To, SK Martin, ...
Cancer research 65 (5), 1700-1709, 2005
TWIST family of basic helix‐loop‐helix transcription factors mediate human mesenchymal stem cell growth and commitment
S Isenmann, A Arthur, ACW Zannettino, JL Turner, S Shi, CA Glackin, ...
Stem cells 27 (10), 2457-2468, 2009
The system can't perform the operation now. Try again later.
Articles 1–20